11/12/2017

SUS incorporates Pertuzumab in the treatment of HER2-positive breast cancer

In these difficult days for the country and for public health, EXCELLENT NEWS: the incorporation, by the SUS, of PERTUZUMAB for the treatment of patients with HER2-positive metastatic breast cancer. This represents More LIVES with more QUALITY!!!

See the ordinance that makes the matter official:

http://portal.imprensanacional.gov.br/todas?p_p_id=101&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&_101_struts_action={46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391}2Fasset_publisher{46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391}2Fview_content&_101_returnToFullPageURL=http{46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391}3A{46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391}2F{46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391}2Fportal.imprensanacional.gov.br{46cf1a6c7461ff493d 31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 2Fweb {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 2Fguest {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 2F all {46cf1c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 2F all {46cf1c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 2F all {46cf1c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 2F all {46cf16c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 3FP_Auth {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712bda94daa5b61391} 3dZctjlyRH {46cf1a6c7461ff493dca70d45967bd1ce7048f85e123712bda94b61391} 26p_p_id {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 3D3 {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 26p_p_ lifecycle {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 3D1 {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 26p_p_state {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e1237b94daa5b61391} Normal 3D {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 26p_p_state_rcv {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} 3d1&_101_AssetEntryId=776420&_101_101_Type=776420_101_101_AssetEntryID=776420&_101_101_Type=776420_101_101_AssetEntryID=776420&_101_101_Type=776420_101_101_AssetEntryID=776420&_101_101_Type=776420_101_101_AssetEntryID=776420&_101_101_Type=776420_101_101_AssetEntryId=776420_101_101_101_Content&_101_groupId=68942&_101_urltitle=Ordinance-N-57-of Dec. 4-December-2017&inheritredirect=true

See other news

Explore the latest content on our Blog now and keep up to date with the main achievements of the Cura Project Institute.

Support cancer research efforts today

Donate or partner to make a difference.
Donate

Stay informed with our newsletter

Sign up for our newsletter to receive regular updates on research progress and news from the institute.